Disparities in mpox vaccine uptake could leave many vulnerable to resurgence
A study by CUNY SPH researchers found that, even as availability of the mpox vaccine increased toward the end of the 2022 outbreak in the U.S., uptake remained low.
Feb 12, 2024
0
0